Wednesday, July 8, 2026
🇺🇸 FDA

biotech · Colorectal Cancer · Psoriatic Arthritis, Rheumatoid Arthritis · CRDF

Cardiff Oncology

Cardiff Oncology patent portfolio — 69 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
11055 Flintkote Avenue, San Diego, California 92121, US HQ
1999 Founded
51 Employees
Public company Type
CRDF · NYSE Ticker
Company details
Status
Public
HQ
11055 Flintkote Avenue, San Diego, California 92121, US
Founded
1999
Employees
51
Programs
58
Drugs
62
Patents
69
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Patents

Cardiff Oncology patents

69 pharmaceutical patents indexed for Cardiff Oncology. 2 expire within 24 months.

Cardiff Oncology has 69 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 2 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

69 patents

Patent portfolio

Page 1 of 2

  1. US 12383540

    Compounds that modulates AMPA receptor function

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12318418

    Modified adenoviruses

    Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12263173

    PLK1 inhibitor in combination with anti-angiogenics for treating metastatic cancer

    Expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12144813

    PLK1 inhibitor in combination with anti-angiogenics for treating metastatic cancer

    Expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12053513

    Cancer-specific T-cell receptors

    Expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11957677

    Cancer treatment using FGFR inhibitors and PLK1 inhibitors

    Expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11850264

    Gamma delta T-cell receptor and its ligand

    Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11725039

    α/β t-cell receptor and methods of using it

    Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11471502

    Neuroprotective peptide

    Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11298345

    Compounds that modulates AMPA receptor function

    Expires Mon Apr 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11260185

    Pressurized metered dose inhalers and method of manufacture

    Expires Mon Feb 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11207687

    Artificial cells

    Expires Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11186567

    AMPA receptor potentiators

    Expires Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11180466

    2-benzoylaminobenzamide derivatives as Bcl-3 inhibitors

    Expires Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11083696

    Dispersion anaesthetic device

    Expires Mon Aug 05 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11078252

    T-cell receptor

    Expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 10655103

    Equine progenitor cells

    Expires Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 10564161

    Method for identifying a bacterial infection

    Expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 10450285

    2-benzoylaminobenzamide derivatives as Bcl-3 inhibitors

    Expires Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 10273218

    BCL-3 inhibitors

    Expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 10209255

    Method for identifying a bacterial infection

    Expires Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 10005810

    Process for preparing nucleoside prodrugs

    Expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9981092

    Pressurised metered dose inhalers and method of manufacture

    Expires Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9918986

    Methods and compounds for preventing osteoarthritis

    Expires Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9895466

    Liposomal drug delivery system for bone cements

    Expires Mon Feb 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9896729

    Method for diagnosing a neurodegenerative disease

    Expires Mon Feb 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9867795

    Nitrated lipids and methods of making and using thereof

    Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9861606

    Therapeutic for treating inflammatory lung disorders

    Expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9827394

    Dispersion anaesthetic device

    Expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9782381

    Molecular targets for healing or treating wounds

    Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9522156

    Nitrated lipids and methods of making and using thereof

    Expires Mon Dec 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9427447

    Anti-viral pyrimidine nucleoside derivatives

    Expires Mon Aug 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9351970

    Anti-viral pyrimidine nucleoside analogues

    Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9351989

    Substituted purine nucleosides, phosphoroamidate and phosphorodiamidate derivatives for treatment of viral infections

    Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9295678

    Nitrated lipids and methods of making and using thereof

    Expires Mon Mar 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9138447

    Antimicrobial agent and method for the production thereof

    Expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9006473

    Nitrated lipids and methods of making and using thereof

    Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8859512

    Anti-viral pyrimidine nucleoside derivatives

    Expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8835380

    Therapeutic conjugates

    Expires Mon Sep 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8759318

    Phosphoramidate derivatives of guanosine nucleoside compounds for treatment of viral infections

    Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8709774

    Sperm factor sequences

    Expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8658616

    Nucleoside aryl phosphoramidates and their use as anti-viral agents for the treatment of hepatitis C virus

    Expires Mon Feb 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8551965

    Anti-viral pyrimidine nucleoside analogues

    Expires Mon Oct 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8551966

    Chemical compounds

    Expires Mon Oct 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8399610

    HPV vaccine comprising peptides from host cell proteins

    Expires Mon Mar 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8357534

    Isolation of human articular cartilage stem cells

    Expires Mon Jan 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8337848

    Monoclonal antibody for APP

    Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8338173

    Preparation of antigen-presenting human γδ T cells and use in immunotherapy

    Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Cardiff Oncology have?

69 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Cardiff Oncology patents expire?

2 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.